Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High Mutation Rates in Non-human Primates Edited by Cytosine Base Editors.

Genomics, proteomics & bioinformatics·2026
Same author

Real-World Efficacy and Safety of TACE Combined with Lenvatinib and PD-1 Inhibitor in Conversion Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE007): A Multicenter Retrospective Study.

Liver cancer·2026
Same author

Image feature embedding with a deep learning framework improves genome-wide association studies on dog endophenotypes.

Science advances·2026
Same author

Social communicative characteristics of adolescent police dogs: Acquired experience plays a crucial role.

Animal cognition·2026
Same author

Fangchinoline restores TFEB-driven lysosomal biogenesis and blocks H1N1 infection.

Acta pharmacologica Sinica·2026
Same author

Neoadjuvant transarterial chemoembolization with tyrosine kinase and immune checkpoint inhibitors improves survival from resectable hepatocellular carcinoma in a multicenter, retrospective study (GUIDANCE002).

Communications medicine·2026

Related Experiment Video

Updated: Jun 27, 2026

Re-Arterialized Rat Partial Liver Transplantation with an in vivo Vessel-Oriented 70% Hepatectomy
14:52

Re-Arterialized Rat Partial Liver Transplantation with an in vivo Vessel-Oriented 70% Hepatectomy

Published on: April 8, 2018

Liver retransplantation: a single-centre experience.

Yi Ma1, Guo-dong Wang, Xiao-shun He

  • 1Organ Transplantation Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China. anhuimayi2002@163.com

Chinese Medical Journal
|December 17, 2008
PubMed
Summary

Liver retransplantation (re-LT) offers a second chance for patients with end-stage liver disease. Optimizing surgical timing and techniques can improve survival rates after re-LT.

More Related Videos

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Related Experiment Videos

Last Updated: Jun 27, 2026

Re-Arterialized Rat Partial Liver Transplantation with an in vivo Vessel-Oriented 70% Hepatectomy
14:52

Re-Arterialized Rat Partial Liver Transplantation with an in vivo Vessel-Oriented 70% Hepatectomy

Published on: April 8, 2018

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Gastroenterology

Background:

  • Liver transplantation (LT) shows encouraging survival rates for end-stage liver disease.
  • Graft loss necessitates liver retransplantation (re-LT), but outcomes are a concern compared to primary LT (PLT).
  • Identifying optimal re-LT strategies is crucial for improving patient survival.

Purpose of the Study:

  • To analyze indications for re-LT.
  • To determine the optimal timing for re-LT.
  • To identify strategies for enhancing survival post-re-LT.

Main Methods:

  • Retrospective analysis of 39 re-LT cases from 738 LTs (2001-2006).
  • Factors analyzed included re-LT indication, Model for End-Stage Liver Disease (MELD) score, interval to re-LT, surgical reconstruction methods, and causes of death.
  • Survival rates were evaluated based on these factors.

Main Results:

  • Higher survival rates were observed in patients with MELD scores < 20.
  • Optimal re-LT timing (interval >30 days or <8 days post-PLT) correlated with better survival.
  • Infection was the leading cause of perioperative death (60.0%); overall 1-year survival was 66.7%.

Conclusions:

  • Favorable outcomes are achievable with liver retransplantation (re-LT).
  • Optimal surgical timing, refined techniques, tailored immunosuppression, and infection management are key to improving re-LT survival.
  • These findings guide strategies for better patient outcomes in re-LT.